New research published in Nature Biotechnology shows that it may be possible to reprogramme cells inside the brain to reverse the symptoms of Parkinson's.
Parkinson's UK and the University of Sheffield have launched a new £1million virtual biotech company, Keapstone Therapeutics, to combine world-leading research from the University with funding and expertise from the charity to develop new treatments.
Researchers have discovered a potential way to tell the difference between people with Parkinson's and those with parkinsonisms using a simple blood test.
A natural molecule called squalamine may hold the key to preventing Lewy bodies forming in Parkinson's, according to groundbreaking new research.
Gut microbes could play a critical role in the development of Parkinson's, according to groundbreaking new research published on Thursday 1 December.